NYSE:CNC Centene (CNC) Stock Price, News & Analysis $73.10 +5.70 (+8.46%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$69.30▼$74.7250-Day Range$64.87▼$78.4352-Week Range$60.83▼$81.42Volume9.64 million shsAverage Volume3.47 million shsMarket Capitalization$39.01 billionP/E Ratio14.53Dividend YieldN/APrice Target$83.93 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Centene alerts: Email Address Centene MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside14.8% Upside$83.93 Price TargetShort InterestHealthy2.56% of Float Sold ShortDividend StrengthN/ASustainability-0.26Upright™ Environmental ScoreNews Sentiment0.07Based on 45 Articles This WeekInsider TradingSelling Shares$688,346 Sold Last QuarterProj. Earnings Growth15.51%From $6.51 to $7.52 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.94 out of 5 starsMedical Sector17th out of 936 stocksHospital & Medical Service Plans Industry2nd out of 11 stocks 3.2 Analyst's Opinion Consensus RatingCentene has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 6 buy ratings, 9 hold ratings, and no sell ratings.Amount of Analyst CoverageCentene has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Centene's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.56% of the float of Centene has been sold short.Short Interest Ratio / Days to CoverCentene has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Centene has recently decreased by 1.02%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldCentene does not currently pay a dividend.Dividend GrowthCentene does not have a long track record of dividend growth. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCentene has received a 52.32% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Health insurance services for individuals", "Commercial health insurance services", and "Health insurance services for groups" products. See details.Environmental SustainabilityThe Environmental Impact score for Centene is -0.26. Previous Next 2.3 News and Social Media Coverage News SentimentCentene has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 45 news articles for Centene this week, compared to 14 articles on an average week.Search InterestOnly 12 people have searched for CNC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows11 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 57% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Centene insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $688,346.00 in company stock.Percentage Held by InsidersOnly 0.33% of the stock of Centene is held by insiders.Percentage Held by Institutions93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Centene's insider trading history. Previous Next 4.4 Earnings and Valuation Earnings GrowthEarnings for Centene are expected to grow by 15.51% in the coming year, from $6.51 to $7.52 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Centene is 14.53, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 143.45.Price to Earnings Ratio vs. SectorThe P/E ratio of Centene is 14.53, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 164.48.Price to Earnings Growth RatioCentene has a PEG Ratio of 0.89. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioCentene has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Centene's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Centene Stock (NYSE:CNC)Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Read More CNC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CNC Stock News HeadlinesJuly 26 at 8:54 PM | msn.comHealth Insurer Centene's Q2 Premium Revenue Cushions Fall In Medicaid Enrollment, Raises Annual OutlookJuly 26 at 1:50 PM | investopedia.comCentene Beats Estimates, Boosts Guidance on Higher Premiums, MembershipsJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 26 at 1:36 PM | americanbankingnews.comCentene (NYSE:CNC) Issues FY 2024 Earnings GuidanceJuly 26 at 8:17 AM | markets.businessinsider.comCentene Corporation Q2 Profit Increases, Beats EstimatesJuly 26 at 8:17 AM | markets.businessinsider.comCentene Backs FY24 Earnings View, Lifts Revenue Forecast - UpdateJuly 26 at 8:17 AM | msn.comCentene posts Q2 beat despite Medicaid headwindsJuly 26 at 7:03 AM | gurufocus.comCentene Corp (CNC) Q2 2024 Earnings: EPS of $2. ...July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 26 at 6:05 AM | reuters.comCentene beats profit estimates after change in govt risk adjustmentJuly 26 at 6:00 AM | prnewswire.comCENTENE CORPORATION REPORTS SECOND QUARTER 2024 RESULTSJuly 25 at 2:50 PM | msn.comJefferies Downgrades Centene (CNC)July 25 at 9:50 AM | markets.businessinsider.comAstrana Health To Acquire Collaborative Health Systems - Quick FactsJuly 25 at 9:50 AM | finance.yahoo.comThose who invested in Centene (NYSE:CNC) five years ago are up 27%July 25 at 8:00 AM | prnewswire.comAstrana Health Enters Definitive Agreement to Acquire Collaborative Health SystemsJuly 25 at 6:18 AM | americanbankingnews.comCentene (NYSE:CNC) PT Lowered to $80.00July 25 at 4:22 AM | americanbankingnews.comCentene (NYSE:CNC) Rating Reiterated by Cantor FitzgeraldJuly 24 at 4:22 PM | markets.businessinsider.comCentene’s Hold Rating Affirmed Amid Medicaid Margin Pressures and Exchange Market UncertaintiesSee More Headlines Receive CNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/26/2024Last Earnings7/26/2024Next Earnings (Confirmed)7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryManaged Health Care Current SymbolNYSE:CNC CUSIP15135B10 CIK1071739 Webwww.centene.com Phone(314) 725-4477Fax314-558-2428Employees67,700Year Founded1984Price Target and Rating Average Stock Price Target$83.93 High Stock Price Target$110.00 Low Stock Price Target$69.00 Potential Upside/Downside+14.8%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)$5.03 Trailing P/E Ratio14.53 Forward P/E Ratio11.23 P/E Growth0.89Net Income$2.70 billion Net Margins1.76% Pretax Margin2.37% Return on Equity14.19% Return on Assets4.42% Debt Debt-to-Equity Ratio0.66 Current Ratio1.17 Quick Ratio1.17 Sales & Book Value Annual Sales$154.00 billion Price / Sales0.25 Cash Flow$10.22 per share Price / Cash Flow7.15 Book Value$48.55 per share Price / Book1.51Miscellaneous Outstanding Shares533,660,000Free Float531,895,000Market Cap$39.01 billion OptionableOptionable Beta0.50 Social Links 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMs. Sarah M. London (Age 43)CEO & Director Comp: $4.98MMr. Kenneth John Fasola (Age 64)President Comp: $4.67MMr. Andrew Lynn Asher (Age 55)Executive VP & CFO Comp: $3.37MMr. Christopher Andrew Koster (Age 59)Executive VP, General Counsel & Secretary Comp: $2.25MMr. David P. Thomas (Age 58)CEO of Markets & Medicaid Comp: $2.86MMs. Susan R. Smith (Age 48)Chief Operating Officer Ms. Katie Nicole Casso (Age 42)Senior VP, Chief Accounting Officer & Corporate Controller Mr. Brian Phillip LeClaire M.B.A. (Age 64)Ph.D., Chief Information Officer Ms. Jennifer Lynch GilliganSenior Vice President of Investor RelationsMs. Ashlee KnuckeyChief Risk, Ethics & Compliance OfficerMore ExecutivesKey CompetitorsElevance HealthNYSE:ELVThe Cigna GroupNYSE:CIHumanaNYSE:HUMMolina HealthcareNYSE:MOHUnitedHealth GroupNYSE:UNHView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 25,595 shares on 7/26/2024Ownership: 1.029%AustralianSuper Pty LtdSold 19,430 shares on 7/26/2024Ownership: 0.256%Railway Pension Investments LtdSold 9,500 shares on 7/26/2024Ownership: 0.056%State of Michigan Retirement SystemBought 2,700 shares on 7/26/2024Ownership: 0.032%GAM Holding AGBought 1,220 shares on 7/26/2024Ownership: 0.017%View All Insider TransactionsView All Institutional Transactions Should I Buy Centene Stock? CNC Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Centene Co.: Centene reported strong earnings per share (EPS) of $2.26 for the quarter, beating the consensus estimate by $0.17, indicating solid financial performance. The company had revenue of $40.41 billion for the quarter, surpassing analysts' expectations, showcasing robust revenue growth. Insider buying activity: Point72 Hong Kong Ltd acquired 131,459 shares of Centene Co., indicating confidence in the company's future prospects. Positive analyst ratings: Multiple analysts have given buy and strong buy ratings for Centene, suggesting a favorable outlook for the stock. Recent stock performance: Despite fluctuations, Centene's stock price has shown resilience, providing potential opportunities for investors. Cons Investors should be bearish about investing in Centene Co. for these reasons: Centene's net margin of 1.76% may indicate lower profitability compared to some other companies in the industry, posing a risk for investors. The company's return on equity of 14.19% is relatively moderate, suggesting potential limitations in generating returns for shareholders. High institutional ownership: 93.63% of the stock is currently owned by institutional investors, which could lead to limited influence for individual investors. Market volatility: Centene's stock has experienced fluctuations in trading, potentially exposing investors to market uncertainties. Analyst caution: While some analysts have positive ratings, others have issued hold recommendations, indicating mixed sentiments about the stock's future performance. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, July 5, 2024. Please send any questions or comments about these Centene pros and cons to contact@marketbeat.com. CNC Stock Analysis - Frequently Asked Questions How have CNC shares performed this year? Centene's stock was trading at $74.21 at the beginning of 2024. Since then, CNC stock has decreased by 1.5% and is now trading at $73.10. View the best growth stocks for 2024 here. How were Centene's earnings last quarter? Centene Co. (NYSE:CNC) released its earnings results on Friday, July, 26th. The company reported $2.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.80 by $0.62. The company's revenue for the quarter was up 5.9% compared to the same quarter last year. When did Centene's stock split? Centene's stock split on the morning of Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were payable to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Is Centene doing a stock buyback? Centene's board approved a share repurchase plan on Friday, December 16th 2022, which allows the company to repurchase $2,000,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 4.3% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's management believes its stock is undervalued. What is Michael F. Neidorff's approval rating as Centene's CEO? 930 employees have rated Centene Chief Executive Officer Michael F. Neidorff on Glassdoor.com. Michael F. Neidorff has an approval rating of 74% among the company's employees. Does Centene have any subsidiaries? The following companies are subsidiaries of Centene: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and others. Who are Centene's major shareholders? Centene's top institutional investors include Swedbank AB (1.90%), Bank of New York Mellon Corp (1.03%), Scharf Investments LLC (0.42%) and Sumitomo Mitsui Trust Holdings Inc. (0.29%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Shannon Bagley, Christopher J Coughlin, Richard A Gephardt, Theodore R Samuels II, Lori Jean Robinson, John R Roberts, Mark J Brooks, Katie Casso, David P Thomas, Christopher Koster, Michael F Neidorff, Colin A Toney, Orlando Ayala and Brent D Layton. View institutional ownership trends. How do I buy shares of Centene? Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Centene own? Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include NVIDIA (NVDA), Alibaba Group (BABA), UnitedHealth Group (UNH), Micron Technology (MU), CVS Health (CVS), Intel (INTC) and Johnson & Johnson (JNJ). This page (NYSE:CNC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
